Govt cracks down on erring pharma units

Shimla: Amid the ongoing anti-drug campaign launched on Nov 15, the Himachal Pradesh Police and drug administration on Wednesday conducted an inspection of the pharmaceutical manufacturing units and uncovered irregularities in four facilities.

These facilities had been either closed, suspended or had surrendered their licenses. The officials concerned confirmed that legal action was being initiated against all the violators.

A total of 20 such pharmaceutical units across the state were inspected on Wednesday to curb the illegal production and trafficking of controlled substances.

Joint teams of police officers and drug inspectors carried out systematic checks, verifying licences, scrutinising documents, auditing stock records, and searching warehouses and production areas, said an official spokesperson.

The drive aims to prevent the misuse of inactive units for manufacturing counterfeit or psychotropic drugs. Surprise inspections were conducted across six districts — Una, Bilaspur, Solan, Sirmaur, and Nurpur and Baddi (police districts), said the spokesperson, adding that five more units were still under review.

The state police said it had a ‘zero-tolerance policy’ toward drug-related offences.

Related Posts

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha has received investment commitments worth ₹7,043 crore across the pharmaceutical and medical technology sectors, marking a major step in strengthening the state’s position as an emerging healthcare manufacturing hub.…

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Mastermind of India’s massive codeine cough syrup racket skips ED summons- what’s next for Shubham Jaiswal? With arrest warrants, Red Corner Notices, and cross-border drug links, the investigation could expose…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Odisha Receives Investment Commitments Worth ₹7,043 Cr in Pharma & Medtech

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Cough Syrup Racket Busted: Kingpin Shubham Jaiswal skips ED summons; Here’s what happens next

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Senores Pharmaceuticals to Acquire Apnar Pharma at Enterprise Value of ₹91 Crore

Aytu BioPharma launches depression drug EXXUA in U.S. market

Aytu BioPharma launches depression drug EXXUA in U.S. market

Delhi govt carries out 27 raids against fake medicine

Delhi govt carries out 27 raids against fake medicine

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16

Odisha Pharma Summit 2025 to Explore Opportunities in Pharmaceutical Sector on December 16